Search Results - "Wim Timens"

Refine Results
  1. 1

    The pathology of chronic obstructive pulmonary disease by Hogg, James C, Timens, Wim

    Published in Annual review of pathology (01-02-2009)
    “…The pathogenesis of chronic obstructive pulmonary disease (COPD) is based on the innate and adaptive inflammatory immune response to the inhalation of toxic…”
    Get full text
    Journal Article
  2. 2

    Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine by Brandsma, Corry‐Anke, Van den Berge, Maarten, Hackett, Tillie‐Louise, Brusselle, Guy, Timens, Wim

    Published in The Journal of pathology (01-04-2020)
    “…Chronic obstructive pulmonary disease (COPD) is a devastating lung disease with a high personal and societal burden. Exposure to toxic particles and gases,…”
    Get full text
    Journal Article
  3. 3

    Can ACE2 expression explain SARS‐CoV‐2 infection of the respiratory epithelia in COVID‐19? by Nawijn, Martijn C, Timens, Wim

    Published in Molecular systems biology (01-07-2020)
    “…Infection with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) leads to coronavirus disease 2019 (COVID‐19), which poses an unprecedented…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Lung ageing and COPD: is there a role for ageing in abnormal tissue repair? by Brandsma, Corry-Anke, de Vries, Maaike, Costa, Rita, Woldhuis, Roy R, Königshoff, Melanie, Timens, Wim

    Published in European respiratory review (31-12-2017)
    “…Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, with increasing prevalence, in particular in the elderly. COPD is…”
    Get full text
    Journal Article
  7. 7

    High miR203a-3p and miR-375 expression in the airways of smokers with and without COPD by van Nijnatten, Jos, Brandsma, Corry-Anke, Steiling, Katrina, Hiemstra, Pieter S., Timens, Wim, van den Berge, Maarten, Faiz, Alen

    Published in Scientific reports (04-04-2022)
    “…Smoking is a leading cause of chronic obstructive pulmonary disease (COPD). It is known to have a significant impact on gene expression and (inflammatory) cell…”
    Get full text
    Journal Article
  8. 8

    Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19 by Hernández Cordero, Ana I., Li, Xuan, Milne, Stephen, Yang, Chen Xi, Bossé, Yohan, Joubert, Philippe, Timens, Wim, van den Berge, Maarten, Nickle, David, Hao, Ke, Sin, Don D.

    Published in Human genetics (01-06-2021)
    “…SARS-CoV-2 is responsible for the coronavirus disease 2019 (COVID-19) and the current health crisis. Despite intensive research efforts, the genes and pathways…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Immune microenvironment composition in non‐small cell lung cancer and its association with survival by Tamminga, Menno, Hiltermann, Thijo Jeroen N, Schuuring, Ed, Timens, Wim, Fehrmann, Rudolf SN, Groen, Harry JM

    “…Objectives In non‐small cell lung cancer (NSCLC), the immune system and possibly its composition affect survival. In this in silico study, the immune…”
    Get full text
    Journal Article
  11. 11
  12. 12

    miR-146a-5p plays an essential role in the aberrant epithelial-fibroblast cross-talk in COPD by Osei, Emmanuel T, Florez-Sampedro, Laura, Tasena, Hataitip, Faiz, Alen, Noordhoek, Jacobien A, Timens, Wim, Postma, Dirkje S, Hackett, Tillie L, Heijink, Irene H, Brandsma, Corry-Anke

    Published in The European respiratory journal (01-05-2017)
    “…We previously reported that epithelial-derived interleukin (IL)-1α drives fibroblast-derived inflammation in the lung epithelial-mesenchymal trophic unit…”
    Get full text
    Journal Article
  13. 13

    Distinct macrophage phenotypes in allergic and nonallergic lung inflammation by Robbe, Patricia, Draijer, Christina, Borg, Thiago R, Luinge, Marjan, Timens, Wim, Wouters, Inge M, Melgert, Barbro N, Hylkema, Machteld N

    “…Chronic exposure to farm environments is a risk factor for nonallergic lung disease. In contrast to allergic asthma, in which type 2 helper T cell (Th2)…”
    Get more information
    Journal Article
  14. 14

    Gene expression network analysis provides potential targets against SARS-CoV-2 by Hernández Cordero, Ana I., Li, Xuan, Yang, Chen Xi, Milne, Stephen, Bossé, Yohan, Joubert, Philippe, Timens, Wim, van den Berge, Maarten, Nickle, David, Hao, Ke, Sin, Don D.

    Published in Scientific reports (14-12-2020)
    “…Cell entry of SARS-CoV-2, the novel coronavirus causing COVID-19, is facilitated by host cell angiotensin-converting enzyme 2 (ACE2) and transmembrane serine…”
    Get full text
    Journal Article
  15. 15

    The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension by Haarman, Meindina G., Kerstjens-Frederikse, Wilhelmina S., Vissia-Kazemier, Theresia R., Breeman, Karel T.N., Timens, Wim, Vos, Yvonne J., Roofthooft, Marc T.R., Hillege, Hans L., Berger, Rolf M.F.

    Published in The Journal of pediatrics (01-10-2020)
    “…To describe the prevalence of pulmonary arterial hypertension (PAH)-associated gene mutations, and other genetic characteristics in a national cohort of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    More alternative activation of macrophages in lungs of asthmatic patients by Melgert, Barbro N., PhD, ten Hacken, Nick H., MD, PhD, Rutgers, Bea, BSc, Timens, Wim, MD, PhD, Postma, Dirkje S., MD, PhD, Hylkema, Machteld N., PhD

    Published in Journal of allergy and clinical immunology (01-03-2011)
    “…[...]a significantly higher percentage of macrophages with an alternatively activated phenotype (ie, either CD206 [macrophage mannose receptor] or stabilin-1…”
    Get full text
    Journal Article
  18. 18

    Adverse pulmonary vascular remodeling in the Fontan circulation by Ridderbos, Floris-Jan S., BSc, Wolff, Djoeke, MD, Timmer, Albertus, MD, PhD, van Melle, Joost P., MD, PhD, Ebels, Tjark, MD, PhD, Dickinson, Michael G., MD, PhD, Timens, Wim, MD, PhD, Berger, Rolf M.F., MD, PhD

    “…Background The Fontan circulation is a palliation for patients with a functionally univentricular heart. It is characterized by gradual attrition over time. An…”
    Get full text
    Journal Article
  19. 19

    Atypical goblet cell hyperplasia occurs in CPAM 1, 2, and 3, and is a probable precursor lesion for childhood adenocarcinoma by Fakler, Fabian, Aykutlu, Umut, Brcic, Luka, Eidenhammer, Sylvia, Thueringer, Andrea, Kashofer, Karl, Kulka, Janina, Timens, Wim, Popper, Helmut

    “…Congenital pulmonary airway malformation (CPAM) is a developmental disorder. Types 1-2-3 are the more common ones. Atypical goblet cell hyperplasia (AGCH) in…”
    Get full text
    Journal Article
  20. 20

    Collagen type XIV is proportionally lower in the lung tissue of patients with IPF by Nizamoglu, Mehmet, Koloko Ngassie, Maunick Lefin, Meuleman, Rhode A., Banchero, Martin, Borghuis, Theo, Timens, Wim, Nawijn, Martijn C., Melgert, Barbro N., Heijink, Irene H., Brandsma, Corry-Anke, Burgess, Janette K.

    Published in Scientific reports (08-11-2023)
    “…Abnormal deposition of extracellular matrix (ECM) in lung tissue is a characteristic of idiopathic pulmonary fibrosis (IPF). Increased collagen deposition is…”
    Get full text
    Journal Article